Selective estrogen receptor modulator (SERM)
Inoue, D.; Matsumoto, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 3): 613-618
2005
ISSN/ISBN: 0047-1852 PMID: 15813137 Document Number: 586022
Document emailed within 1 workday
Related Documents
Burckhardt, P. 1999: Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy Schweizerische Medizinische Wochenschrift 129(49): 1926-1930Ohta, H. 2008: Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis Clinical Calcium 18(10): 1442-1450
Sugiyama, N.; Sasayama, D.; Amano, N. 2007: Remarkable antidepressant augmentation effect of raloxifene, a selective estrogen receptor modulator, in a partial responder to fluvoxamine: a case report Journal of Clinical Psychiatry 68(4): 636-637
Imai, Y.; Kato, S. 2010: Effects of SERMs on bone health. Mechanisms of bone mass control by selective estrogen receptor modulator Clinical Calcium 20(3): 339-344
van den Brûle, F.A.; Kalbus, M.F.; Gaspard, U.J. 1999: Raloxifene: a selective modulator of estrogen receptors Journal de Gynecologie Obstetrique et Biologie de la Reproduction 28(8): 788-799
Yanase, T. 2016: A potential of selective androgen receptor modulator(SARM)for the therapy of osteoporosis Clinical Calcium 26(7): 1023-1030
Levy, G.; Elkas, J.; Armstrong, A.Y.; Nieman, L.K. 2016: Endometrial Effects of Prolonged Therapy with the Selective Progesterone Receptor Modulator Ulipristal Acetate: A Case Report Journal of Reproductive Medicine 61(3-4): 159-162
Huang, Y.; Jensen, J.T.; Brache, V.; Cochon, L.; Williams, A.; Miranda, M.-J.é; Croxatto, H.; Kumar, N.; Sussman, H.; Hoskin, E.; Plagianos, M.; Roberts, K.; Merkatz, R.; Blithe, D.; Sitruk-Ware, R. 2014: A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception Contraception 90(6): 565-574
Hayashi, T. 2011: Estrogen, SERM Nihon Rinsho. Japanese Journal of Clinical Medicine 69(7): 1270-1274
Yanase, T.; Tanabe, M.; Nomiyama, T. 2014: Transdisciplinary Approach for Sarcopenia. Appication of selective androgen receptor modulator to the therapy of sarcopenia Clinical Calcium 24(10): 1501-1508
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283
Matsumoto, T. 2006: Selective estrogen receptor modulators (SERMs) Clinical Calcium 16(9): 1520-1525
Meczekalski, B.ła.; Czyzyk, A. 2009: Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis Ginekologia Polska 80(3): 213-217
Simoncini, T.; Mannella, P.; Genazzani, A.R. 2003: Cardiovascular effects of selective estrogen receptor modulators. Current perspectives Recenti Progressi in Medicina 94(2): 51-56
Chandrasekar, B. 2000: Selective estrogen receptor modulators in coronary artery disease--are they here to stay? Indian Heart Journal 52(4): 487-490
Vokrouhlická, J.; Pavo, I.; Stĕpán, J. 1998: Selective estrogen receptor modulators as a new concept in preventing health risks of menopause Casopis Lekaru Ceskych 137(22): 679-685
Kahán, Z. 1996: Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?) Orvosi Hetilap 137(42): 2305-2308
Picariello, L.; Fiorelli, G.; Martineti, V.; Tognarini, I.; Pampaloni, B.; Tonelli, F.; Brandi, M.Luisa. 2003: Growth response of colon cancer cell lines to selective estrogen receptor modulators Anticancer Research 23(3b): 2419-2424
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939